Received Dec 8, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 2 | 3053481 | IM / LL |
| DTAP | DTAP (INFANRIX) | GLAXOSMITHKLINE BIOLOGICALS | 4 | JP227 | IM / RL |
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 1 | Z005852 | IM / RL |
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | 4 | UK304AA | IM / LL |
Second dose of Covid19 Moderna vaccine was given too early. First dose was administered 11/13/25 and second dose was administered 12/2/25. There was 19 days between doses one and two instead of the recommended 28 days. No adverse symptoms noted per Mom.
none
GERD, sleep disorder, food protein-induced proctocolitis
OTC iron supplement
milk
None